Agilent announces alissa interpret selected by north west genomic laboratory hub for clinical genomic analysis

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) today announced its clinical informatics platform alissa interpret has been adopted by the north west genomic laboratory hub (nw glh) based in manchester and liverpool, part of manchester university nhs foundation trust, england. the nw glh and its partners are responsible for delivering genomic testing across the whole of the north west. alissa interpret, which enables clinical genetics labs to standardize and automate v
A Ratings Summary
A Quant Ranking